RegenLab® USA logo with cellular icon and the words 'Tissue Engineering Specialists
RegenLab® USA logo with cellular icon and the words 'Tissue Engineering Specialists
RegenLab® USA logo with cellular icon and the words 'Tissue Engineering Specialists

RL USA LLC Patents

Blue light bulb with green gear inside representing innovation and ideas

Quality Management

Learn More
Blue clipboard with data, magnifying glass, and green-filled tube representing research and discovery

Regulatory

Learn More
The RegenLab® patent portfolio relates to the protection of devices & methods for the preparation of Platelet-Rich Plasma, biological glue/gel, Autologous Thrombin Serum (ATS), combination of PRP with cell extracts like Bone Marrow Concentrate (BMC) and fat tissue as well as the major/breakthrough technological innovation Cellular Matrix® which combines PRP and hyaluronic acid (HA). Combinatory Preparations involving BMC, fat tissue, and PRP+HA are still under investigation in the U.S. and as such are not currently available for purchase in the country. 

The patent portfolio can be divided into two core technologies:

1-PRP/BMC gel devices, methods and uses thereof, alone or in combination with cell extracts and associated key technologies like Autologous Thrombin Serum (ATS) and PRP Cell Culture.

Associated trademarks are REGENLAB®, REGENKIT®, REGENACR®, PRP®, A-PRP®, REGENCELL®, REGENPLASMA®, REGEN PRP®, REGEN®, REGEN EXTRACELL®, THT®, cellularmask®, CUTECELL®, REGENVET®, A-CPKIT® which are registered trademarks of REGEN LAB SA in Europe, United States and other countries.

2-Hyaluronic acid alone, cross-linked or not, or in combination with PRP/BMC leading to the unique “all in one” Cellular Matrix products combining in a synergetic manner the advantageous properties of PRP and HA, but also preparation in two separate devices.

Associated trademarks are REGENLAB®, REGENKIT®, CELLULAR MATRIX® fig., SKINVISC®, ARTHROVISC®, REGENMATRIX®, REGEN®, PRP® and A-PRP® which are registered trademarks of REGEN LAB in Europe, United States and other countries.

Cellular Matrix®, RegenMatrix™, CellularWound™, RegenBMC™, SkinVisc™, ArthroVisc™, and RegenARP™

are under investigation in the U.S., and as such are not currently available for commercial sale within the country.

RegenLab®, Regen®, RegenKit®, THT®, RegenBMC®, RegenPlasma®, RegenCell®, VetPRP®, CellularMatrix®, A-PRP® & BioBridge®

are U.S. registered trademarks of RegenLab USA and/or Regen Lab SA.

RegenWound™, RegenPRP™, RegenMatrix™, RegenARP™, ArthroVisc™, SkinVisc™, Generation Regeneration™ & RegenVet™

are U.S. pending trademarks of RegenLab USA and/or Regen Lab SA.

April 1, 2025

Table in PDF

Pin It on Pinterest